Red wavelength should not be forgotten, Professor Michael Stur advises.
First patient dosed in Phase 1/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio)
SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Renal dysfunction negatively impacts effect of diabetic macular oedema therapy
Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Heidelberg Engineering announces two-day International SPECTRALIS Symposium
The event will include presentations on artificial intelligence, ocular imaging and surgical topics
US FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel
